Adage Capital Management, L.P. bought $1.9M of SLDB
owner at Solid Biosciences Inc.. 252,545 shares at an average of $7.56, traded Feb 18, 2025, filed Feb 19, 2025.
Score components
- +12Role10% owner
- +25Trade size$1.9M at market
- +3Relative to holdingsHoldings up 6%
- 0Price contextNo price history yet
- +15Cluster3 insiders buying within 14 days
- 0Repeat buyingFirst buy in 90 days
- 0Track recordToo few past buys to judge (0 with prices)
- -5Outside holderA 10% owner who is not an officer or director
What happened after comparable buys
Same side and tier, against the S&P 500, at 1, 3 and 6 months. Shown to Pro users; the whole table is on the backtest page.
Price around the trade, and since
From a quarter before the trade to today. The arrow is the trade, the circle the day the filing reached EDGAR, which is the first day anyone outside could act; the dotted line is the S&P 500 rebased to that day's close.
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value; the dashed line is the close on the filing day, the dotted line SPY rebased to it.Charts by TradingView Lightweight Charts™
Rows in this filing
Every transaction in Form 4 0000902664-25-001114, as filed. Open on EDGAR
| Date | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|
| Feb 18, 2025 | POpen-market purchase Common Stock, $0.001 par value per shareindirect: See footnotes | +252,545 | $7.56 | $1.9M | 4,248,084 | Feb 19, 2025 |
Related signals
Other insiders at Solid Biosciences Inc. and this insider’s other filings.
| Score | Company | Insider | Value | Holdings | Filed |
|---|---|---|---|---|---|
| 25Weak | SLDBbuy Solid Biosciences Inc. | Clare Kahn director | $9,924 1,860 shares | +169% | |
| 53Moderate | Solid Biosciences Inc. | Bain Capital Life Sciences Investors, LLC owner | $4.0M 1,000,000 shares | +25% | |
| 65Notable | Solid Biosciences Inc. | Perceptive Advisors LLC director, owner | $20M 5,000,000 shares | +73% | |
| 0Weak | Solid Biosciences Inc. | Gabriel Brooks Chief Medical Officer | $13k 3,256 shares | -12% | |
| 16Weak | Solid Biosciences Inc. | Alexander Cumbo President and CEO | $45k 11,365 shares | -16% | |
| 0Weak | Solid Biosciences Inc. | Ilan Ganot director | $6,776 1,711 shares | -10% | |
| 0Weak | Solid Biosciences Inc. | Jessie Hanrahan Chief Regulatory Officer | $12k 3,079 shares | -14% | |
| 0Weak | Solid Biosciences Inc. | Paul Herzich Chief Technology Officer | $11k 2,688 shares | -13% | |
| 5Weak | Solid Biosciences Inc. | David T Howton Chief Operating Officer | $22k 5,561 shares | -18% | |
| 0Weak | Solid Biosciences Inc. | Ilan Ganot director | $448 144 shares | -1% |
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.